FDA Authorizes First At-Home COVID-19 and Flu Combo Test Samantha Anderer JAMA. 2024;332(21):1779. doi:10.1001/jama.2024.22561 Full Text The US Food and Drug Administration (FDA) recently granted authorization to market the first at-home influenza and COVID-19 combination test outside of...
Flu & COVID-19 Combo product description The Influenza & COVID-19 Ag Combo Rapid Test is an in vitro immunochromatographic assay for the rapid, qualitative detection of nucleocapsid protein antigen from SARS-CoV-2 in human nasal swab specimen....
INFLUENZA vaccinesMESSENGER RNAA phase 3 clinical trial conducted by BioNTech and Pfizer on a combination mRNA vaccine for COVID-19 and influenza yielded mixed results. The trial involved over 8,000 healthy adults aged 18 to 64 who were randomly assigned to different va...
"Flu and COVID-19 represent a significant seasonal burden for individuals, providers, healthcare systems and economies," Moderna CEO Stéphane Bancel said earlier this month in a statement when phase I/II clinical trial data was released. "Combination vaccines offer ...
However, influenza and COVID-19 vaccines are designed and manufactured in different platforms, all the individuals will need to get two shots in order to prevent those two severe respiratory diseases. Therefore, it is urgent to develop a Flu-COVID combo vaccine to provide an efficient way for...
Regardless, Marks said the FDA is working on "a robust grouping of data" vetting the safety and effectiveness of administering separate shots for flu and COVID-19 on the same day. The FDA haspreviously announcedplans to formally study a potential rare safety issue that was flagged this past ...
its experimental combination vaccines for COVID-19 and influenza, each being evaluated in separate phase I/II studies. While the first combination pairs the Fluzone HD vaccine with Novavax’s COVID-19 vaccine, the second combines Sanofi’s Flubok influenza vaccine with the NVAX COVID-19 ...
posted positive data against influenza A butdisappointing results against influenza B. However, in June,Moderna reported preliminary datashowing its experimental flu and Covid-19 combination vaccine met the main goal of a Phase 3 test, including positive marks against both influenza A and influenza ...
Novavax’s upcoming Phase III trial will evaluate the efficacy of the CIC vaccine in adults aged 65 and older by comparing its immune response against those produced by standard flu and Covid-19 vaccines. The trial will also investigate the effectiveness of Novavax’s investigat...
Immune responses between combo vaccine and mono vaccines of each component were compared to confer that combo vaccine did not alter the immunogenicity of each vaccine component and the immune responses elicited by the combo vaccine were equivalent to those elicited by either Flu or COVID-19 mono ...